Abbott Labs (ABT) Tops Q3 EPS by 3c; Raises FY14 EPS Midpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Mylan (MYL), Abbott (ABT) Enter Amended Agreement; Will be Accretive to Mylan
October 22, 2014 7:26 AM EDTOn October 21, 2014, Mylan Inc. (Nasdaq: MYL), a Pennsylvania corporation, New Moon B.V., a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) organized under the laws of the Netherlands, Moon of PA Inc., a Pennsylvania corporation, and Abbott Laboratories (NYSE: ABT), an Illinois corporation, entered into an amendment in connection with pre-closing actions required to be taken pursuant to the Business... More
